| Literature DB >> 34274366 |
Yavuz Orak1, Filiz Alkan Baylan2, Aydemir Kocaslan3, Erdinc Eroglu3, Mehmet Acipayam3, Mehmet Kirisci3, Omer Faruk Boran4, Adem Doganer5.
Abstract
BACKGROUND: Cardiopulmonary bypass (CPB) causes systemic oxidative stress response and endothelial damage in systemic organs. We investigated the effects of positive end-expiratory pressure (PEEP) and mechanical ventilation (MV) applications on oxidative stress in CPB.Entities:
Keywords: Cardiopulmonary bypass; Oxidative stress; Peep; Tidal volume
Mesh:
Substances:
Year: 2021 PMID: 34274366 PMCID: PMC9373507 DOI: 10.1016/j.bjane.2021.06.024
Source DB: PubMed Journal: Braz J Anesthesiol ISSN: 0104-0014
Figure 1Consort diagram of the study.
Demographic and clinical information.
| Group 1 (n = 20) | Group 2 (n = 20) | Group 3 (n = 20) | KW/χ2/F | ||||
|---|---|---|---|---|---|---|---|
| Age | Median (Q1–Q3) | 63.50 (56.0–72.0) | 58.00 (40.5–69.5) | 52.00 (40.0–67.5) | 3.736x | 0.154 | |
| Sex | Female | n (%) | 10 (50.0) | 10 (50.0) | 12 (60.0) | 0.536z | 0.765 |
| BMI** | Mean ± SD | 28.81 ± 3.43 | 28.67 ± 5.05 | 28.46 ± 5.01 | 0.030y | 0.971 | |
| Smokers | n (%) | 3 (15.0) | 1 (5.0) | 1 (5.0) | 1.745z | 0.418 | |
| Diabetes Mellitus | Yes | n (%) | 10 (50.0) | 4 (20.0) | 6 (30.0) | 4.200z | 0.122 |
| No | n (%) | 10 (50.0) | 16 (80.0) | 14 (70.0) | |||
| Hypertension | Yes | n (%) | 15 (75.0) | 9 (45.0) | 6 (30.0) | 8.400z | |
| No | n (%) | 5 (25.0) | 11 (55.0) | 14 (70.0) | |||
KW, Kruskal-Wallis H test; χ2, chi-square test; F, Fisher’s exact test; Anova Test Statistics; ** one-way ANOVA; α: 0.05; post-hoc: Tukey’s HSD test; * the difference between groups is statistically significant; xKruskal Wallis H test; y one-way ANOVA (F); z Chi-square/Exact (χ2); BMI: body mass index.
Surgery information.
| Group 1 | Group 2 | Group 3 | KW/F/X2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N % | N | % | |||||
| Types of surgery | CABG | 14 | 70.0 | 9 | 45.0 | 10 | 50.0 | 13,558z | 0.845 |
| MVR | 1 | 5.0 | 1 | 5.0 | 1 | 5.0 | |||
| Aortic aneurysm | 0 | 0.0 | 1 | 5.0 | 2 | 10.0 | |||
| AVR | 1 | 5.0 | 1 | 5.0 | 1 | 5.0 | |||
| ASD | 2 | 10.0 | 2 | 5.0 | 3 | 15.0 | |||
| Atrial myxoma | 1 | 5.0 | 0 | 0.0 | 0 | 0.0 | |||
| CABG + MVR | 0 | 0.0 | 2 | 10.0 | 0 | 0.0 | |||
| AVR + MVR | 0 | 0.0 | 2 | 10.0 | 2 | 10.0 | |||
| TVR + MVR | 1 | 5.0 | 1 | 5.0 | 0 | 0.0 | |||
| VSD | 0 | 0.0 | 1 | 5.0 | 1 | 5.0 | |||
| IO Fluid (mL) | 675.00 (525.00–700.00) | 550.00 (400.00–675.00) | 500.00 (375.00–600.00) | 4.450x | 0.108 | ||||
| IO Urine**(mL) | 1025.00 ± 498.00 | 1270.00 ± 505.00 | 1204.00 ± 704.00 | 0.964y | 0.388 | ||||
| Left Ventricle E/F | 55.00 (50.00–60.00) | 57.50 (52.50–60.00) | 57.50 (55.00–60.00) | 1.037x | 0.595 | ||||
| CPB Duration (min) | 98.00 (72.00–117.50) | 128.50 (99.00–162.00) | 102.00 (79.00–121.50) | 5.157x | 0.076 | ||||
| Cross-clamp Time (min) | 57.50 (41.00–95.00) | 76.50 (57.00–124.00) | 62.00 (43.00–95.00) | 2.136x | 0.344 | ||||
| Operation Time** | 245.00 ± 54.90b | 300.75 ± 66.34a, c | 248.00 ± 65.18b | 5.058y | |||||
| Postoperative Intubation Time (min) | 460.00 (360.00–705.00) | 345.00 (255.00–697.50) | 375.00 (315.00–570.00) | 2.385x | 0.303 | ||||
| ICU Stay (days) | 3.00 (3.00–4.00) | 3.00 (3.00–4.00) | 3.00 (2.50–4.50) | 0.135x | 0.935 | ||||
KW: Kruskal-Wallis H test; χ2: chi-square test; Exact test; F:Anova Test Statistics; ** one-way ANOVA; α: 0.05; post-hoc: Tukey’s HSD test; xKruskal Wallis H test;Post-hoc: Dunn Sidak test; y one-way ANOVA (F); z Exact test (χ2)* difference between groups is statistically significant; a the difference between this group and Group 1 is statistically significant; b the difference between this group and Group 2 is statistically significant; c the difference between this group and Group 3 is statistically significant; CABG: Coronary artery bypass graft; MVR: Mitral valve replacement; AVR: Aortic valve replacement; ASD: Atrial septal defect; TVR: Tricuspid valve replacement; VSD: Ventricular septal defect. IO: Intraoperative; E/F: Ejection/Fraction; CPB: Cardiopulmonary bypass; ICU: intensive care unit; Fluid: NaCl.0.9%.
Comparison of the preoperative, intraoperative, and postoperative oxidative stress levels.
| Group 1 (n = 20) | Group 2 (n = 20) | Group 3 (n = 20) | ||
|---|---|---|---|---|
| Preoperative GPX | 0.011 (0.007–0.014) | 0.014 (0.011–0.019)z | 0.01 (0.008–0.013)y | |
| Intraoperative GPX | 0,010 (0.004–0.015) | 0.012 (0.010–0.015) | 0.014 (0.007–0.025) | 0.260 |
| Postoperative GPX | 0,009 (0.005–0.013) | 0.013 (0.012–0.015)z | 0.009 (0.006–0.011)y | |
| 0.538 | 0.297 | 0.350 | ||
| Preoperative CAT | 6.09 (2.68–10.56)c | 10.70 (5.21–20.77) | 6.58 (2.64–11.79) | 0.423 |
| Intraoperative CAT | 10.07 (3.66–15.07) | 12.74 (9.22–19.57)c | 8.55 (4.12–14.89) | 0.218 |
| Postoperative CAT | 13.76 (8.80–18.02)a | 5.77 (0.99–23.80)b | 10.38 (6.27–25.03) | 0.085 |
| 0.522 | ||||
| Preoperative TAS | 3.07 (2.97–3.19)z | 3.37 (3.10–3.64)z | 4.32 (4.14–4.37)x, y | |
| Intraoperative TAS | 3.01 (2.91–3.26)z | 3.26 (3.00–3.59)c, z | 4.32 (4.20–4.35)c, x, y | |
| Postoperative TAS | 3.13 (3.05–3.26)y, z | 3.79 (3.59–4.16)b, x, z | 4.46 (4.334.67)b, x, y | |
| 0.259 | ||||
| Preoperative MDA | 1.52 (1.31–1.86)z | 1.48 (1.27–1.92) | 1.29 (1.08–1.41)b, c, x | |
| Intraoperative MDA | 1.33 (1.17–2.89)z | 1.49 (1.40–2.67)z | 2.78 (2.45–3.08)a, x, y | |
| Postoperative MDA | 1.64 (1.36–1.91)z | 1.43 (1.25–1.80)z | 3.45 (2.95–3.94)a, x, y | |
| 0.522 | 0.949 | |||
| Preoperative TOS | 19.65 (16.50–29.80) | 17.20 (12.40–26.50)b, c, z | 41.30 (19.55–56.70)y | |
| Intraoperative TOS | 28.00 (22.95–34.55)y | 86.50 (67.10–110.00)a, x, z | 51.10 (35.55–70.60)y | |
| Postoperative TOS | 18.60 (17.65–25.85)y, z | 41.80 (34.20–53.10)a, x | 37.05 (33.95–42.65)x | |
| 0.091 | 0.387 | |||
| Preoperative TT | 318.28 (277.82–404.27) | 334.70 (310.82–369.34)c | 337.69 (147.35–368.74) | 0.797 |
| Intraoperative TT | 337.39 (290.96–392.48)z | 336.79 (312.61–388.15)c, z | 287.97 (271.70–323.36)x, y | |
| Postoperative TT | 411.58 (355.15–440.40) | 450.25 (358.29–475.33)a, b | 358.29 (302.90–452.34) | 0.907 |
| 0.212 | 0.058 | |||
| Preoperative NT | 239.58 (206.31–538.11)b | 237.98 (212.60–266.34)b | 258.66 (226.25–284.89)b | 0.477 |
| Intraoperative NT | 208.12 (175.28–221.02)a, c | 194.69 (168.67–214.95)a, c | 190.10 (165.37–219.42)a, c | 0.802 |
| Postoperative NT | 238.19 (217.82–258.34)b | 252.05 (213.24–287.87)b | 241.81 (223.80–284.25)b | 0.444 |
Kruskal Wallis H Test; Friedman test; Post hoc: Bonferroni test; Dunn-Sidak test; α: 0.05; * the difference between measurements is statistically significant; a the difference between this measurement and the preoperative measurement is statistically significant; b the difference between this measurement and the intraoperative measurement is statistically significant; c the difference between this measurement and the postoperative measurement is statistically significant. x the difference between this group and Group 1 is statistically significant; y the difference between this group and Group 2 is statistically significant; z the difference between this group and Group 3 is statistically significant; GPx: glutathione peroxidase (u.mL-1), MDA: malondialdehyde (nmol.mL-1), CAT: catalase (u.mL-1), TAS: total antioxidant status mmol.L-1, TOS; total oxidant status µmol.L-1, TT: total thiol (µmol.L-1), NT: native thiol (µmol.L-1).